The 17 analysts offering 12-month price forecasts for Ionis Pharmaceuticals Inc have a median target of 70.00, with a high estimate of 120.00 and a low estimate of 19.00. The median estimate represents a +16.41% increase from the last price of 60.13.
The current consensus among 20 polled investment analysts is to Hold stock in Ionis Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.94
Reporting Date Feb 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.